Aino Health AB (publ): interim report january-september 2024
This document in English is a translation of the original in Swedish.…
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024
COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced…
NINER Pharmaceutical Strengthens Global Presence with Strategic IV Fluid Supply Initiative for the U.S. and Latin American Markets
DUBAI, United Arab Emirates, Nov. 15, 2024 (GLOBE NEWSWIRE) -- NINER Pharmaceutical,…
International Cancer Organizations Present Collaborative Work During Oncology Event in China
The National Comprehensive Cancer Network (NCCN) is honored to participate in the…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
This Diabetes Day Heal Beyond Medicine with Dharana at Shillim
MUMBAI, India, Nov. 14, 2024 /PRNewswire/ -- In today's fast-paced world, diabetes…
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented…
Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 14, 2024 07:05 ET | Source: Invivyd Q3 2024 PEMGARDA™ (pemivibart)…
Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor
November 14, 2024 07:01 ET | Source: Invivyd The New England Journal…
Tilray Medical Launches its First Commercial Grown in Germany Medical Cannabis Products Under its Newly Expanded Cultivation License
NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division…
